Share
ISSN: 1665-2681
ANNALS OF HEPATOLOGY is an international open access journal published bimonthly and is funded by Medica Sur Clinical Foundation, Mexico City, Mexico. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin-American Association for the Study of the Liver (ALEH) and the Canadian Association for the Study of the Liver (CASL) and publishes original papers, concise reviews, letters to the Editor, invited editorials, opinions and viewpoints in the field of Hepatology.
ANNALS OF HEPATOLOGY'S main topics are alcoholic liver disease, viral hepatitis (HAV, HBV, HCV, HDV, HEV), NAFLD/NASH, genetic liver diseases, autoimmune hepatitis, drug¿induced liver injury and biliary diseases. The journal's aim is to publish articles focused on basic, clinic care and translational research that seeks to prevent rather than treat the complications of endstage liver disease.
Indexed in:
Scopus, Web of Science, Medline
See moreFollow us:
1.895 (2018)
Impact Factor
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years.
© Clarivate Analytics, Journal Citation Reports 2017 2018
Impact Factor 2018
1.895
CiteScore 2018
CiteScore measures average citations received per document published. Read more
CiteScore 2018
1.55
SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.
SJR
0.628
SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.
SNIP
0.638
Hide
Issue
Pages 227-338 (May - June 2020)
Editorial
Looking into a new era for the approach of metabolic (dysfunction) associated fatty liver disease
Alejandro Valencia-Rodríguez, Alfonso Vera-Barajas, Norberto C. Chávez-Tapia, Misael Uribe, Nahum Méndez-Sánchez
Ann Hepatol. 2020;19:227-9
Open access
Opinions
Expanding TACTICS trial into a different setting in hepatocellular carcinoma
Leonardo da Fonseca, Flair José Carrilho
Ann Hepatol. 2020;19:230-1
Open access
Concise reviews
Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review
Victor Cunha, Helma Pinchemel Cotrim, Raquel Rocha, Kellyane Carvalho, Liliane Lins-Kusterer
Ann Hepatol. 2020;19:232-7
Open access
Bacterial infections in cirrhosis: Current treatment
Godolfino Miranda-Zazueta, Luis A. Ponce de León-Garduño, Jonathan Aguirre-Valadez, Aldo Torre-Delgadillo
Ann Hepatol. 2020;19:238-44
Open access
Association between sarcopenia and hepatic encephalopathy: A systematic review and meta-analysis
Karn Wijarnpreecha, Monia Werlang, Panadeekarn Panjawatanan, Paul T. Kroner, Wisit Cheungpasitporn, Frank J. Lukens, Surakit Pungpapong, Patompong Ungprasert
Ann Hepatol. 2020;19:245-50
Open access
Original articles
Polycystic ovary syndrome with feasible equivalence to overweight as a risk factor for non-alcoholic fatty liver disease development and severity in Mexican population
Nicolás Salva-Pastor, Guillermo Nahúm López-Sánchez, Norberto Carlos Chávez-Tapia, Jorge Román Audifred-Salomón, Danniela Niebla-Cárdenas, Rafael Topete-Estrada, Helga Pereznuñez-Zamora, Rafael Vidaltamayo-Ramírez, Margarita Elodia Báez-Arellano, Misael Uribe, Natalia Nuño-Lámbarri
Ann Hepatol. 2020;19:251-7
Open access
Prevalence of liver fibrosis in an unselected general population with high prevalence of obesity and diabetes mellitus. Time for screening?
Diego García-Compeán, Jesús Zacarías Villarreal-Pérez, Manuel Enrique de la O. Cavazos, Fernando Javier Lavalle-Gonzalez, Omar David Borjas-Almaguer, Angel Noé Del Cueto-Aguilera, José Alberto González-González, Consuelo Treviño-Garza, Lourdes Huerta-Pérez, Héctor Jesús Maldonado-Garza
Ann Hepatol. 2020;19:258-64
Open access
The effects of hyperthermia on human hepatocellular carcinoma stem and mature cancer cells
David Sontag, David A. Miles, Julia Uhanova, Micah Grubert Van Iderstine, Jiaqi Yang, Gerald Y. Minuk
Ann Hepatol. 2020;19:265-8
Open access
Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p/HK2 axis
Zhenghua Ding, Li Guo, Zhongming Deng, Peng Li
Ann Hepatol. 2020;19:269-79
Open access
Requirement of cyclin-dependent kinase function for hepatitis B virus cccDNA synthesis as measured by digital PCR
Ching-Yu Bao, Hsu-Chin Hung, Yi-Wen Chen, Chiao-Yuan Fan, Chien-Jung Huang, Wenya Huang
Ann Hepatol. 2020;19:280-6
Open access
New model predicting gastroesophageal varices and variceal hemorrhage in patients with chronic liver disease
Jia-li Ma, Ling-ling He, Yu Jiang, Jun-ru Yang, Ping Li, Yao Zang, Hong-shan Wei
Ann Hepatol. 2020;19:287-94
Open access
Serological and molecular study of Hepatitis E virus in pediatric patients in Mexico
Tayde López-Santaella, Teresa Álvarez y Muñoz, Mara Medeiros-Domingo, Sarbelio Moreno-Espinosa, Alejandra Consuelo-Sánchez, Onofre Muñoz-Hernández, Rosa Elena Sarmiento-Silva, Alicia Sotomayor-González, María Elena Trujillo-Ortega, Montserrat Elemi García-Hernández, Blanca Itzel Taboada-Ramírez, Francisco Arenas-Huertero
Ann Hepatol. 2020;19:295-301
Open access
Identification and study of differentially expressed miRNAs in aged NAFLD rats based on high-throughput sequencing
Ying Zhang, Danni Xiang, Xiaona Hu, Qingwei Ruan, Lina Wang, Zhijun Bao
Ann Hepatol. 2020;19:302-12
Open access
Comparing hepatic steatosis distribution patterns between non-alcoholic fatty liver disease and fatty liver disease with chronic hepatitis B by second-harmonic generation/two-photon excited fluorescence method
Zhenjie Zhuang, Huanjia Qu, Wenjun Yang, Juan Liu, Fuyan Wang, Yinlan Liu, Jianping Ding, Junping Shi
Ann Hepatol. 2020;19:313-9
Open access
Meta-analysis: The efficacy of metformin and other anti-hyperglycemic agents in prolonging the survival of hepatocellular carcinoma patients with type 2 diabetes
Jian Zhou, Yang Ke, Xuefen Lei, Tiangen Wu, Yuehua Li, Tianhao Bao, Haoran Tang, Cheng Zhang, Xuesong Wu, Ge Wang, Jinze Li, Heng Zhang, Fan Ni, Zhengchen Ye, Lin Wang
Ann Hepatol. 2020;19:320-8
Open access
48 weeks outcome after cessation of nucleos(t)ide analogue therapy in chronic hepatitis B patients
Li Gao, Yue Hu, Xiaofeng Shi, Xin Li, Dazhi Zhang, Hong Ren
Ann Hepatol. 2020;19:329-34
Open access
Case report
Liver transplantation in the setting of a spontaneous shunt between superior mesenteric vein and right renal vein
Marcio F. Chedid, Sofia Zahler, Aljamir D. Chedid, Ian Leipnitz, João E. Prediger, Angelo Z.D. Giampaoli, Bruno B. Lopes, Cleber R.P. Kruel, Tomaz J.M. Grezzana-Filho
Ann Hepatol. 2020;19:335-7
Open access
Letters to the editor
Primary biliary cholangitis with autoimmune hepatitis features: What's the appropriate criteria to evaluate the treatment-response?
Xiaoli Fan, Haoran Wang, Mengyi Shen, Li Yang
Ann Hepatol. 2020;19:338
Open access
Special content about COVID-19
Publish in
Annals of Hepatology
Affiliated societies
